Introduction
Upon microbial invasion the immune system must first sense the microbe's presence and then rapidly deliver an appropriate response. This requires the precise coordination of several simultaneous tasks that include 1) influx of immediate immune effectors, such as neutrophils and NK cells; 2) activation of antigen-specific memory B and T lymphocytes into effector cells; and 3) priming of naïve lymphocytes that leads to recruitment of more effector cells and, upon primary infection, establishment of immune memory. This complex program is thought to be coordinated by dendritic cells (DCs) [1] [2] [3] .
DCs constitute a complex system of cells with common and unique functions. Human blood contains two DC subsets, myeloid (mDCs) and plasmacytoid (pDCs) 3, 4 . mDCs demonstrate remarkable plasticity and, depending on cytokine environment, can differentiate into either macrophages (with M-CSF), or distinct subsets of tissue-localized DCs, i.e., epithelial Langerhans cells (with IL-15 or TGF-β) or interstitial DCs (with IL-4). Upon activation, mDCs secrete IL-12 and mature into antigen presenting cells able to prime T cells. pDCs are considered poor antigen presenting cells, but are major producers of type I interferons upon viral activation 5 .
DCs attract immune effectors through CKs [6] [7] [8] [9] and regulate their maturation and function through cell-cell contact, and/or soluble factors [1] [2] [3] . Several studies analyzed CK secretion by DCs either generated ex vivo and exposed to bacterial products 10 or sorted from the blood and exposed to Influenza virus upon culture with GM-CSF and IL-4
(mDCs) or GM-CSF and IL-3 (pDCs) 11, 12 . Furthermore, secretion of a limited set of CKs was analyzed at a single time point post viral exposure 13 . Thus, there is a paucity of knowledge about the kinetics of CK response of primary blood DC subsets exposed to only.
For personal use at PENN STATE UNIVERSITY on . bloodjournal.hematologylibrary.org From 4 live Influenza virus. As DCs need to coordinate the different steps of an immune response, we surmised that viral infection might trigger a sequential program of CK secretion that may permit such coordination.
Materials and Methods
DC purification, staining and culture. pDCs and mDCs were purified from normal donor's buffy coats. Ficoll enriched PBMCs were depleted of lineage positive cells with CD3, CD14, CD19, CD16, CD56, and glycophorin A microbeads (Miltenyi Biotec).
After staining with lineage cocktail-FITC, CD11c-APC and CD123-PE (BD Biosciences) and HLA-DR-QR (Sigma) mAbs, cells were sorted on a FACSVantage™ (Becton Dickinson) to >99% purity. For phenotype analysis, DCs were stained as above, but replacing the CD123-PE with CD123 biotin/streptavidin-Alexa Fluor 405 (Molecular Probes), sorted on a FACSAria™ (Becton Dickinson), and stained before or after influenza virus infection using PEconjugated CD83, CD40 (Beckman Coulter); CD80, CD86 (BD Bioscience).
Microarray samples preparation and Genechip array hybridization. Cell pellets (250,000 cells) were resuspended in RLT buffer (Quiagen) and frozen at -80°C. Total RNA was extracted with RNeasy columns (Quiagen), and analyzed with the 2100 Bioanalyser only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From (Agilent). Amplification: total RNA (300ng) was reverse transcribed 2h at 42°C in the presence of 1 μM T7-(dT)24 oligonucleotide (Operon), 1X first strand buffer, 10 mM DTT, 0.75 mM dNTP, 20 U/μl Superscript II reverse transcriptase (all from Invitrogen), and 2 U/μl RNAse inhibitor (Ambion). Second strand synthesis was achieved by incubation for 2h at 16°C, after addition of 1X second strand buffer, 0.2 mM dNTP, 0.07 U/μl E. coli DNA ligase, 0.27 U/μl E. coli DNA polymerase I, 0.013 U/μl E. coli RNAse H, and then addition of 0.13 U/μl of T4 DNA polymerase (all from Invitrogen) for 10min at 16°C. Double stranded cDNA was precipitated with 0.5 M ammonium acetate and 70% ethanol, and first round of in vitro transcription was performed for 6h at 37°C, in the presence of 1X Megascript buffer, 30mM dNTP, 1X Megascript T7 enzyme mix (all from Ambion). Amplified cRNA was cleaned up using an RNeasy mini kit column (Quiagen), and quantified by migration on a 2100 Bioanalyser. Second reverse transcription was performed as for the first round but using 100 pM of a random hexamer pd(N)6 (Roche), and after treatment with 0.2 U/μl of RNAse H at 37°C for 20min and enzyme heat inactivation, second strand synthesis was performed by addition of 0.13 μM T7-(dT)24 oligonucleotide, 1X second strand buffer, 0.2 mM dNTP, 0.27 U/μl E. coli DNA polymerase I; and incubation at 16°C for 2h. Double strand cDNA was then purified using the cDNA cleanup module from Affymetrix, and in vitro transcription was performed using the Enzo RNA transcript labeling kit (Affymetrix). Finally, biotin labeled cRNA was purified using the cRNA cleanup module (Affymetrix), and stored at -80°C until hybridization. Microarray data analysis. Raw intensity values from each chip were first pre-scaled to the 500 target intensity value in Affymetrix Microarray suite (MAS 5.0), before being imported in GeneSpring 6.1 (Silicon Genetics). Chips quality was evaluated by analyzing variability within the parameters of MAS expression report: scale factor, average background, percentage of present calls, 3' bias for GAPDH and actin, and spike control expression; we verified that the value for each chip was included within the mean ± two standard deviations. In GeneSpring, for per chip normalization, each measurement on each chip was normalized to the 50th percentile of the measurements on that chip; for per gene normalization, the measurement of each probe was normalized to the median of the measurements of that probe in the different chips. Before applying any statistical test, the normalized intensities were then log transformed, and gene lists were filtered; first on flags, excluding genes that were called absent in all chips; and then on confidence using a t-test p value with no multiple testing correction, selecting genes whose expression was varying significantly across the experiment. Finally, samples were grouped by conditions (pDCs vs mDCs, and non infected vs virus infected), for statistical group comparison using ANOVA test (analysis of variance) with a Bonferroni multiple testing correction.
To analyze gene expression of selected gene list, chips were normalized with a per chip normalization without any per gene normalization, nor any log transformation. We thus arbitrary considered as significantly expressed genes whose normalized intensity was 3 times higher that the 50 th percentile. Statistical comparison of cell migration was done using two-tailed paired t-test.
only.
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Results

Influenza virus triggers a common CK production program in human pDCs and mDCs
To determine the global CK production program triggered in human DC subsets upon viral exposure, we used gene microarray analysis in mDCs and pDCs purified from six healthy donors, before and 24h after in vitro exposure to Influenza virus (Influenza A/PR/8/34). Statistical comparison and analysis of fold change expression values showed that Influenza virus up-regulated 4,712 probe sets in pDCs and 4,560 probe sets in mDCs (data not shown). Twenty of these differentially expressed transcripts encoded CKs (Fig.   1a ), leading us to carry out a systematic analysis of Influenza virus induced CK transcript expression in mDCs and pDCs (44 CK probe sets were present on the U133 chips).
Transcripts with expression levels at least 3-fold over the 50th percentile were considered significant (Fig 1b) . Thus, 4/44 CKs were significantly expressed in both DC subsets before activation (CXCL4, CXCL7, CXCL8, and CXCL16) (Fig. 1b and 1c) . mDCs expressed more CXCL8 (x7) and CXCL16 (x36) than pDCs, whereas levels of CXCL4 and CXCL7 were comparable (Fig. 1b and 1c , Table S1 ). Moreover, mDCs, which displayed a more activated phenotype based on CD86, CD83, and HLA-DR expression (Fig. S1 ), also expressed CCL3 and CXCL2. CXCL4 is a major product of platelets [14] [15] [16] previously not identified in DCs. Although the lack of reagents does not permit to demonstrate the production of CXCL4 by DCs, the purity of DC preparations determined by FACS analysis and the absence of platelet specific gene expression exclude a possible platelet contamination.
Upon exposure to influenza virus for 24h, expression of these 4 CKs was reduced and 12 other were turned on in both pDCs and mDCs (Fig. 1b and c, Table S1 ). These 
Influenza virus triggers a coordinated CK production program with three successive waves
To analyze the kinetics of CK expression, purified DCs (25,000 cells) were exposed to Influenza virus (1/125 HA titer per microL); pellets and supernatants were collected at 4, 8, 16, 24 and 48h (Fig. 2) . Before viral exposure, CXCL4 and CXCL16
were actively transcribed in both subsets ( Fig. 2a and b) . The CXCL16 protein was however detected in mDCs but not pDCs supernatants (Fig. 2d) . CXCL16, which like CX3CL1, is expressed as a transmembrane protein 19 is cleaved by a metalloprotease and attracts effector cells expressing the CXCR6 receptor 20, 21 . The expression of CXCL4 has been found earlier in platelets 14, 15 and monocytes 22 . The transcription of both CXCL4
and CXCL16 is down-regulated upon viral exposure.
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In the early post-viral exposure phase, 2-4h, DCs transcribe mainly CXCL1, CXCL2, CXCL3, and CXCL8 that are known to attract PMNCs 23 . The peak of their transcription occurred ~ 2h post-exposure and subsequently decreased ( Fig. 2e and f) .
CXCL8 protein could be detected in supernatants of both pDCs and mDCs 4h post exposure, and reached a maximum at 12h (Fig. 2g and h ).
At intermediate phase (4 to 8h) post-viral exposure, the transcription of the inflammatory CKs CCL3, CCL4, and CCL5 ( Fig. 2i and j) and the interferon-regulated CKs CXCL9, CXCL10, and CXCL11 was induced in both mDCs and pDCs ( Fig. 2m and n). Transcription of these genes reached its peak at 8h, while corresponding protein expression was detected in supernatants at 12h for CCL3 and CCL4 ( Fig. 2k and l) , and 24h for CCL5, CXCL9, and CXCL10 (Fig. 2k, l, o and p) . All of the CKs produced at the intermediate time points are known to attract activated memory T cells 24 . Furthermore, the CKs CCL3, CCL4, and CCL5, are chemotactic for CCR5 expressing monocytes and DCs 18 .
Finally, at late time points (>12h post-exposure), CCL19, CCL22 and CXCL13 transcripts were expressed by both pDCs and mDCs ( Fig. 2q and r) . The CKs could be detected in supernatants 24 to 48h after viral exposure ( Fig. 2s and t) . These CKs attract lymphocytes. CCL19 is chemotactic for CCR7 expressing cells 25 , i.e., naïve and central memory T cells (CD45RA+/-, CCR7+) 26, 27 , as well as mature DCs 28, 29 . CCL22 attracts Th2 effector memory T cells 30 . CXCL13 is the main CK responsible for B cell attraction 31, 32 . Finally, two monocyte chemoattractants, CCL2 and CCL8, were expressed predominantly by mDCs (Fig.2u, v, w and x) . Interestingly, we did not observe CCL17 expression by mDCs, which seems in contrast to earlier study 11 . A possible explanation only.
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Influenza virus-triggered DC subsets attract monocytes, NK cells and effector memory CD4+T cells
We next analyzed the attraction of different immune effectors using an in vitro migration assay. Supernatants of DC subsets, exposed to Influenza virus for 24h, were added in the lower part of a migration chamber. PBMCs, isolated from four healthy volunteers, were added on top of a 3 um pore diameter filter. Migration of different immune cells was analyzed by viable cell count and flow cytometry after 45min incubation to determine which immune effectors are attracted in the early phase post-viral exposure. As shown in Fig. 3a , supernatants of DCs exposed to Influenza virus attracted more PBMCs (mean ± SD = 587x10 3 3 for control medium; p= 0.04; n=4; Fig. 3d ). These results suggest that early after exposure to virus both mDCs and pDCs attract innate immune effectors and effector memory CD4+T cells.
Discussion
Our results demonstrate that upon exposure to live Influenza virus freshly isolated blood mDCs and pDCs produce three waves of CKs, which allow attraction of immune effectors. Though pDCs and mDCs strikingly differ in their biology, they display a remarkably similar pattern of CK secretion despite some qualitative (CCL2, CCL8 and CXCL16 expressed in mDCs only) and quantitative (CCL3, CCL4, and CCL5 expressed at higher levels in pDCs) differences. Such sequential CK secretion program might actually explain how the DCs coordinate immune responses as they mature and migrate towards lymphoid organs (Fig. 4) . Interestingly, this sequential CK program is reminiscent of the sequential CK secretion triggered by LPS in cultured DCs 10 . These results suggest that the various DC subsets share a common program to attract immune effectors.
For Blood DCs expressing at the steady state CXCR4 and CXCR3 can migrate through virally infected tissues, expressing CXCL12, CXCL9, CXCL10, and CXCL11. There, they can penetrate the tissues. Upon encountering the virus, they start to release at the only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From 22 first step CXCL16, CXCL1, CXCL2, CXCL3, CXCL7, and CXCL8. These CKs attract Th1 effectors cells expressing CXCR6 and neutrophils expressing CXCR2 (1). Later, activated DCs secrete CCL2, CCL3, CCL4, CCL5, and CCL8, which essentially attract CCR5 expressing memory T lymphocytes and monocytes (2) . Upon maturation, DCs upregulates CCR7 and down-regulates CXCR4, allowing with L-selectin expression their migration to high endothelial venules expressing CCL21 in lymphoid organs. In the T cell area, activated pDCs secrete CCL19 and CXCL13, which respectively attract CCR7 expressing naïve T cells and CXCR5 expressing naïve B cells (3) . They also secrete CCL22, attracting CCR4 expressing Th2 and CD4+CD25+ regulatory cells (3) .
